Yuka Tsukamoto

Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission

Toshiaki Konishi, Yasuyuki Okamoto, Miki Ueda et al. · Endocrine Journal · 2010 · 53 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +13

The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis

Takao Fujisawa, M Takahashi, Yuka Tsukamoto et al. · Human Molecular Genetics · 2015 · 47 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Subcutaneous Panniculitislike Tcell Lymphoma: Successful Initial Treatment with Prednisolone and Cyclosporin A

Yuka Tsukamoto, Katsunobu Yoshioka, Yoko Omura et al. · Internal Medicine · 2006 · 37 citations · Full text

Medicine, Hematology, Immunology +16

Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity

Toshiko Ishikawa, Motoki Okano, Akiko Minami et al. · Behavioural Brain Research · 2018 · 27 citations · Full text

Medicine, Neuroscience, Pharmacology +17

A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants

Takao Fujisawa, Namiko Yamaguchi, Hisae Kadowaki et al. · Neurobiology of Disease · 2015 · 12 citations

Life Sciences, Neurobiology, Neuroscience +16